Vycor Medical, Inc. (VYCO)
USD 0.07
(0.0%)
USD 0.07
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 1.05 Million USD | 10.04% |
| 2022 | 956.89 Thousand USD | 23.19% |
| 2021 | 776.75 Thousand USD | -15.67% |
| 2020 | 921.08 Thousand USD | 78.96% |
| 2019 | 514.67 Thousand USD | 19.05% |
| 2018 | 432.33 Thousand USD | 285.39% |
| 2017 | 112.18 Thousand USD | -56.85% |
| 2016 | 259.99 Thousand USD | 919.48% |
| 2015 | -31.72 Thousand USD | 97.98% |
| 2014 | -1.56 Million USD | -387.06% |
| 2013 | 546.88 Thousand USD | -74.39% |
| 2012 | 2.13 Million USD | 211.65% |
| 2011 | 685.28 Thousand USD | -43.7% |
| 2010 | 1.21 Million USD | 10.83% |
| 2009 | 1.09 Million USD | 24.65% |
| 2008 | 881.05 Thousand USD | 179.74% |
| 2007 | 314.96 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 1.03 Million USD | -1.3% |
| 2024 Q2 | 941.99 Thousand USD | -9.36% |
| 2023 Q2 | 892.25 Thousand USD | -2.95% |
| 2023 FY | 1.05 Million USD | 10.04% |
| 2023 Q4 | 1.05 Million USD | -1.0% |
| 2023 Q3 | 1.06 Million USD | 19.2% |
| 2023 Q1 | 919.4 Thousand USD | -3.92% |
| 2022 Q1 | 843.94 Thousand USD | 8.65% |
| 2022 FY | 956.89 Thousand USD | 23.19% |
| 2022 Q3 | 927.69 Thousand USD | 7.7% |
| 2022 Q4 | 956.89 Thousand USD | 3.15% |
| 2022 Q2 | 861.4 Thousand USD | 2.07% |
| 2021 Q3 | 819.97 Thousand USD | -6.77% |
| 2021 Q2 | 879.52 Thousand USD | -9.19% |
| 2021 FY | 776.75 Thousand USD | -15.67% |
| 2021 Q1 | 968.49 Thousand USD | 5.15% |
| 2021 Q4 | 776.75 Thousand USD | -5.27% |
| 2020 Q1 | 719.92 Thousand USD | 39.88% |
| 2020 Q3 | 923.78 Thousand USD | 19.93% |
| 2020 FY | 921.08 Thousand USD | 78.96% |
| 2020 Q4 | 921.08 Thousand USD | -0.29% |
| 2020 Q2 | 770.27 Thousand USD | 6.99% |
| 2019 Q3 | 507.01 Thousand USD | -3.93% |
| 2019 FY | 514.67 Thousand USD | 19.05% |
| 2019 Q1 | 476.6 Thousand USD | 10.24% |
| 2019 Q2 | 527.78 Thousand USD | 10.74% |
| 2019 Q4 | 514.67 Thousand USD | 1.51% |
| 2018 FY | 432.33 Thousand USD | 285.39% |
| 2018 Q2 | 409.34 Thousand USD | 50.7% |
| 2018 Q4 | 432.33 Thousand USD | -3.87% |
| 2018 Q3 | 449.73 Thousand USD | 9.87% |
| 2018 Q1 | 271.62 Thousand USD | 142.13% |
| 2017 Q4 | 112.18 Thousand USD | 430.95% |
| 2017 FY | 112.18 Thousand USD | -56.85% |
| 2017 Q1 | -230.3 Thousand USD | -188.58% |
| 2017 Q2 | -201.86 Thousand USD | 12.35% |
| 2017 Q3 | 21.12 Thousand USD | 110.47% |
| 2016 FY | 259.99 Thousand USD | 919.48% |
| 2016 Q1 | 222.2 Thousand USD | 800.38% |
| 2016 Q4 | 259.99 Thousand USD | -44.47% |
| 2016 Q3 | 468.18 Thousand USD | 14.35% |
| 2016 Q2 | 409.44 Thousand USD | 84.26% |
| 2015 Q2 | -695.41 Thousand USD | 27.18% |
| 2015 FY | -31.72 Thousand USD | 97.98% |
| 2015 Q4 | -31.72 Thousand USD | 89.07% |
| 2015 Q3 | -290.34 Thousand USD | 58.25% |
| 2015 Q1 | -954.95 Thousand USD | 39.17% |
| 2014 Q2 | -173.02 Thousand USD | -976.67% |
| 2014 Q1 | 19.73 Thousand USD | -96.39% |
| 2014 FY | -1.56 Million USD | -387.06% |
| 2014 Q4 | -1.56 Million USD | 25.04% |
| 2014 Q3 | -2.09 Million USD | -1110.35% |
| 2013 Q3 | 495.72 Thousand USD | -80.86% |
| 2013 Q2 | 2.59 Million USD | 2.77% |
| 2013 Q1 | 2.52 Million USD | 18.0% |
| 2013 FY | 546.88 Thousand USD | -74.39% |
| 2013 Q4 | 546.88 Thousand USD | 10.32% |
| 2012 Q3 | 1.8 Million USD | 24.01% |
| 2012 Q4 | 2.13 Million USD | 18.32% |
| 2012 Q1 | 1.23 Million USD | 80.54% |
| 2012 Q2 | 1.45 Million USD | 17.64% |
| 2012 FY | 2.13 Million USD | 211.65% |
| 2011 Q1 | 1.67 Million USD | 37.75% |
| 2011 Q2 | -385.42 Thousand USD | -122.99% |
| 2011 FY | 685.28 Thousand USD | -43.7% |
| 2011 Q3 | -199.14 Thousand USD | 48.33% |
| 2011 Q4 | 685.28 Thousand USD | 444.12% |
| 2010 FY | 1.21 Million USD | 10.83% |
| 2010 Q3 | 452.07 Thousand USD | 99.01% |
| 2010 Q2 | 227.16 Thousand USD | -55.6% |
| 2010 Q1 | 511.66 Thousand USD | -53.41% |
| 2010 Q4 | 1.21 Million USD | 169.25% |
| 2009 FY | 1.09 Million USD | 24.65% |
| 2009 Q4 | 1.09 Million USD | -9.46% |
| 2009 Q3 | 1.21 Million USD | 9.52% |
| 2009 Q2 | 1.1 Million USD | 10.33% |
| 2009 Q1 | 1 Million USD | 13.94% |
| 2008 FY | 881.05 Thousand USD | 179.74% |
| 2008 Q4 | 881.05 Thousand USD | 0.0% |
| 2007 FY | 314.96 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| BioElectronics Corporation | 14.82 Million USD | 92.898% |
| Medical Supply International USA, Inc. | 216.6 Thousand USD | -386.112% |
| Polarean Imaging plc | -5.94 Million USD | 117.707% |
| Avitar, Inc. | 5.17 Million USD | 79.638% |
| CVR Medical Corp. | - USD | -Infinity% |
| IR-Med Inc. | -606 Thousand USD | 273.755% |
| AVITA Medical, Inc. | -26.23 Million USD | 104.014% |
| Manhattan Scientifics, Inc. | -7000.00 USD | 15142.243% |
| Össur hf. | 395.08 Million USD | 99.733% |
| Zecotek Photonics Inc. | 2.76 Million USD | 61.883% |
| QHSLab, Inc. | 1.72 Million USD | 39.134% |
| Wellstar International, Inc. | 51.36 Million USD | 97.95% |
| Össur hf. | 395.08 Million USD | 99.733% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | -4.61 Million USD | 122.805% |
| Escalon Medical Corp. | 315.68 Thousand USD | -233.546% |
| Aurora Spine Corporation | 1.9 Million USD | 44.804% |
| BrainsWay Ltd. | -10.32 Million USD | 110.203% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 2.41 Million USD | 56.4% |
| Hamilton Thorne Ltd. | 18.12 Million USD | 94.191% |
| Vivos Inc. | -1.59 Million USD | 166.129% |
| MicroPort Scientific Corporation | 673.58 Million USD | 99.844% |
| Kelyniam Global, Inc. | 487.33 Thousand USD | -116.065% |
| REMSleep Holdings, Inc. | -540.98 Thousand USD | 294.637% |
| CYduct Diagnostics, Inc. | 640.19 Thousand USD | -64.474% |
| Nanomix Corporation | 11.38 Million USD | 90.755% |
| Theraclion SA | -5.86 Million EUR | 117.955% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 3.98 Million USD | 73.58% |
| Positron Corporation | 1.68 Million USD | 37.58% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.61 Million USD | 34.633% |
| Lombard Medical, Inc. | 11.49 Million USD | 90.84% |
| ALR Technologies Inc. | 19.14 Million USD | 94.501% |
| Stratec SE | 119.12 Million USD | 99.116% |
| Heart Tronics, Inc. | 54.99 Thousand USD | -1814.641% |
| Nu-Med Plus, Inc. | 93.19 Thousand USD | -1029.855% |
| Perimeter Medical Imaging AI, Inc. | -13.78 Million USD | 107.637% |
| SANUWAVE Health, Inc. | 30.14 Million USD | 96.507% |
| VMS Rehab Systems, Inc. | 133.52 USD | -788513.691% |
| Guided Therapeutics, Inc. | 1.46 Million USD | 28.224% |
| Ingen Technologies, Inc. | 630.91 Thousand USD | -66.893% |
| Odyssey Group International, Inc. | 2.1 Million USD | 50.045% |
| United American Healthcare Corporation | -9.32 Million USD | 111.289% |
| ECGI Holdings, Inc. | 3.17 Million USD | 66.797% |
| Capital Group Holdings, Inc. | -3508.00 USD | 30115.878% |
| ADM Tronics Unlimited, Inc. | 262.61 Thousand USD | -300.946% |
| Urologix, Inc. | 4.61 Million USD | 77.184% |
| Rapid Therapeutic Science Laboratories, Inc. | 4.2 Million USD | 74.986% |
| Nexeon MedSystems Inc. | 3.33 Million USD | 68.392% |
| SS Innovations International, Inc. | 1.18 Million USD | 11.169% |
| Qualis Innovations, Inc. | 6671.00 USD | -15684.095% |
| Smith & Nephew plc | 2.77 Billion USD | 99.962% |
| NIOX Group Plc | -23.93 Million USD | 104.4% |
| Fuse Medical, Inc. | 1.75 Million USD | 40.019% |
| Broncus Holding Corporation | -81.42 Million USD | 101.293% |
| Brain Scientific Inc. | 2.11 Million USD | 50.233% |
| Pressure BioSciences, Inc. | 22.67 Million USD | 95.357% |
| Health Logic Interactive Inc. | 39.55 Thousand USD | -2561.873% |